
Oncology NEWS International
- Oncology NEWS International Vol 6 No 7
- Volume 6
- Issue 7
NCI Seeks Young Research Talent
BETHESDA, Md--The National Cancer Institute has announced a new program to give outstanding new scientists their first crack at independent research, and to do so for up to four years in NCI labs.
BETHESDA, Md--The National Cancer Institute has announced a new programto give outstanding new scientists their first crack at independent research,and to do so for up to four years in NCI labs.
Investigators selected for the NCI Scholars Program will receive upto $600,000 for salary, space, equipment, and staff during their NCI tour.They will then be eligible for another two years of noncompetitive fundingof up to $125,000 annually at an academic institution.
The NCI said that it expects to select about 10 participants the firstyear. Scientists with no more than five years of postdoctoral researchin basic, clinical, or population-based research on cancer are eligible.Years spent in clinical training do not count against the five-year limit.
A key goal is to increase the NCI's ability to attract highly talentedyoung scientists and to help academic institutions spot potential new investigators.
Harold Varmus, MD, director of the National Institutes of Health, notedthat NIH traditionally has trained scientists who have left to assume leadershiproles elsewhere. "This program continues that tradition," hesaid.
A Spectrum of Research Fields
NCI will consider scientists from a spectrum of research fields. Someexamples include cell biology, gene regulation, environmental determinantsof cancer, signal transduction, pharmacoepidemiology, methodologic andstatistical research, molecular biology of angiogenesis, and the translationof basic findings to clinical settings.
For additional information, potential candidates can contact VincentJ. Cairoli, PhD, chief, Cancer Training Branch, Executive Plaza North,Room 520, Rockville, MD 20892-7390. Telephone: 301-496-8580. Fax: 301-402-4472.E-mail:
Articles in this issue
over 28 years ago
Researchers Report Conflicting Data on Cervical Cancer in AIDSover 28 years ago
CIN Website Now Offers Daily Online Cancer Newspaperover 28 years ago
Members Sought for Director's Consumer Liaison Group: NCIover 28 years ago
Trial Attempts to Reverse Taxol Resistance in Ovarian Cancerover 28 years ago
Taxotere Bests Adriamycin in Metastatic Breast Cancerover 28 years ago
Antiemetic Tablets Prove Equal in Efficacy to IV Drug Regimenover 28 years ago
Preop Chemotherapy May Have Advantages in Primary Breast Cancerover 28 years ago
Doxorubicin Benefits Older Breast Cancer PatientsNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.

















































































